willowbrook hospice

Live MatureMidDeclining

willowbrook hospice Company Information

Share WILLOWBROOK HOSPICE

Company Number

02808633

Shareholders

-

Group Structure

View All

Industry

Hospital activities

 

Registered Address

portico lane, eccleston park, prescot, merseyside, L34 2QT

willowbrook hospice Estimated Valuation

£3.6m

Pomanda estimates the enterprise value of WILLOWBROOK HOSPICE at £3.6m based on a Turnover of £5.9m and 0.61x industry multiple (adjusted for size and gross margin).

willowbrook hospice Estimated Valuation

£270.2k

Pomanda estimates the enterprise value of WILLOWBROOK HOSPICE at £270.2k based on an EBITDA of £64k and a 4.22x industry multiple (adjusted for size and gross margin).

willowbrook hospice Estimated Valuation

£25m

Pomanda estimates the enterprise value of WILLOWBROOK HOSPICE at £25m based on Net Assets of £9.9m and 2.53x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Willowbrook Hospice Overview

Willowbrook Hospice is a live company located in merseyside, L34 2QT with a Companies House number of 02808633. It operates in the hospital activities sector, SIC Code 86101. Founded in April 1993, it's largest shareholder is unknown. Willowbrook Hospice is a mature, mid sized company, Pomanda has estimated its turnover at £5.9m with declining growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Willowbrook Hospice Health Check

Pomanda's financial health check has awarded Willowbrook Hospice a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 4 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating4.5out of 5
positive_score

5 Strong

positive_score

2 Regular

positive_score

4 Weak

size

Size

annual sales of £5.9m, make it larger than the average company (£4.7m)

£5.9m - Willowbrook Hospice

£4.7m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of -2%, show it is growing at a slower rate (8%)

-2% - Willowbrook Hospice

8% - Industry AVG

production

Production

with a gross margin of 34.8%, this company has a comparable cost of product (34.8%)

34.8% - Willowbrook Hospice

34.8% - Industry AVG

profitability

Profitability

an operating margin of -1.6% make it less profitable than the average company (9.9%)

-1.6% - Willowbrook Hospice

9.9% - Industry AVG

employees

Employees

with 87 employees, this is above the industry average (56)

87 - Willowbrook Hospice

56 - Industry AVG

paystructure

Pay Structure

on an average salary of £42.8k, the company has a higher pay structure (£33.9k)

£42.8k - Willowbrook Hospice

£33.9k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £67.6k, this is equally as efficient (£75.7k)

£67.6k - Willowbrook Hospice

£75.7k - Industry AVG

debtordays

Debtor Days

There is insufficient data available for this Key Performance Indicator!

- - Willowbrook Hospice

- - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 19 days, this is quicker than average (31 days)

19 days - Willowbrook Hospice

31 days - Industry AVG

stockdays

Stock Days

it holds stock equivalent to 0 days, this is less than average (12 days)

0 days - Willowbrook Hospice

12 days - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 204 weeks, this is more cash available to meet short term requirements (42 weeks)

204 weeks - Willowbrook Hospice

42 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 5%, this is a lower level of debt than the average (41.6%)

5% - Willowbrook Hospice

41.6% - Industry AVG

WILLOWBROOK HOSPICE financials

EXPORTms excel logo

Willowbrook Hospice's latest turnover from March 2024 is £5.9 million and the company has net assets of £9.9 million. According to their latest financial statements, Willowbrook Hospice has 87 employees and maintains cash reserves of £2 million as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010
Turnover5,880,9366,104,8296,076,4406,331,2145,643,9134,859,5874,662,9814,548,4415,063,9624,434,1563,861,1423,588,6383,102,9343,365,9302,606,268
Other Income Or Grants
Cost Of Sales3,836,5704,063,4993,797,1194,142,7643,858,8173,297,0633,056,0282,846,4863,175,1922,842,8052,472,2322,347,5982,074,0372,180,7661,983,862
Gross Profit2,044,3662,041,3302,279,3212,188,4501,785,0961,562,5241,606,9531,701,9551,888,7701,591,3511,388,9101,241,0401,028,8971,185,164622,406
Admin Expenses2,139,3651,109,355446,415244,0321,355,4491,635,4461,778,2291,619,1791,359,036882,9751,050,5771,047,765988,665436,496651,385
Operating Profit-94,999931,9751,832,9061,944,418429,647-72,922-171,27682,776529,734708,376338,333193,27540,232748,668-28,979
Interest Payable7,7668,4119,487
Interest Receivable
Pre-Tax Profit31,695869,9731,497,4441,565,161336,907-86,225-186,48552,780417,852561,494262,386148,72231,525540,341-28,372
Tax
Profit After Tax31,695869,9731,497,4441,565,161336,907-86,225-186,48552,780417,852561,494262,386148,72231,525540,341-28,372
Dividends Paid
Retained Profit31,695869,9731,497,4441,565,161336,907-86,225-186,48552,780417,852561,494262,386148,72231,525540,341-28,372
Employee Costs3,722,1063,424,4293,133,4693,082,5943,263,9173,015,7632,841,5302,610,6442,438,4082,323,3802,286,9972,151,0261,896,9081,710,5521,622,488
Number Of Employees87899089102102989386867770666162
EBITDA*64,0401,095,4602,011,4092,128,855637,652186,09987,745306,686714,941721,031352,703311,984150,612844,84958,533

* Earnings Before Interest, Tax, Depreciation and Amortisation

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010
Tangible Assets4,198,7694,134,4604,231,7794,374,9994,543,2004,704,1664,803,1664,939,8125,038,0194,493,9713,576,6673,388,4413,388,8613,241,2102,789,232
Intangible Assets
Investments & Other1,703,866604,668648,017644,981597,020660,736650,580679,513643,105672,585639,632637,107595,087580,844676,772
Debtors (Due After 1 year)
Total Fixed Assets5,902,6354,739,1284,879,7965,019,9805,140,2205,364,9025,453,7465,619,3255,681,1245,166,5564,216,2994,025,5483,983,9483,822,0543,466,004
Stock & work in progress1,1299,7557,9638,2882,4979,14811,2808,59110,67110,12613,02816,28516,32218,66114,713
Trade Debtors13,000
Group Debtors
Misc Debtors391,160458,4701,048,193309,724349,273307,177235,324451,782322,015624,648380,550221,258114,33891,770172,980
Cash2,019,2443,209,6773,475,7752,827,5051,278,286538,606496,721422,910351,803475,272475,063496,354468,363479,187242,963
misc current assets2,069,9422,015,000
total current assets4,481,4755,692,9024,531,9313,145,5171,630,056854,931743,325883,283684,4891,110,046868,641733,897599,023602,618430,656
total assets10,384,11010,432,0309,411,7278,165,4976,770,2766,219,8336,197,0716,502,6086,365,6136,276,6025,084,9404,759,4454,582,9714,424,6723,896,660
Bank overdraft
Bank loan17,00016,30014,60014,80015,00014,100
Trade Creditors 200,922234,605132,799176,227273,007234,550121,662138,29564,840124,681104,12991,29779,10833,35048,718
Group/Directors Accounts
other short term finances
hp & lease commitments96911,70319,947
other current liabilities312,813358,745310,221285,493358,980168,904157,015204,096194,591758,643181,980134,228160,68593,91294,945
total current liabilities513,735593,350443,020478,720648,287418,054294,446369,094293,478883,324286,109225,525239,793127,262143,663
loans215,514215,887232,584247,205261,707277,813
hp & lease commitments96912,672
Accruals and Deferred Income
other liabilities
provisions
total long term liabilities215,514215,887232,584247,205262,676290,485
total liabilities513,735593,350443,020694,234864,174650,638541,651631,770583,963883,324286,109225,525239,793127,262143,663
net assets9,870,3759,838,6808,968,7077,471,2635,906,1025,569,1955,655,4205,870,8385,781,6505,393,2784,798,8314,533,9204,343,1784,297,4103,752,997
total shareholders funds9,870,3759,838,6808,968,7077,471,2635,906,1025,569,1955,655,4205,870,8385,781,6505,393,2784,798,8314,533,9204,343,1784,297,4103,752,997
Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010
Operating Activities
Operating Profit-94,999931,9751,832,9061,944,418429,647-72,922-171,27682,776529,734708,376338,333193,27540,232748,668-28,979
Depreciation159,039163,485178,503184,437208,005259,021259,021223,910185,20712,65514,370118,709110,38096,18187,512
Amortisation
Tax
Stock-8,6261,792-3255,791-6,651-2,1322,689-2,080545-2,902-3,257-37-2,3393,94814,713
Debtors-67,310-589,723738,469-39,54942,09671,853-216,458129,767-302,633244,098159,292106,9209,568-68,210172,980
Creditors-33,683101,806-43,428-96,78038,457112,888-16,63373,455-59,84120,55212,83212,18945,758-15,36848,718
Accruals and Deferred Income-45,93248,52424,728-73,487190,07611,889-47,0819,505-564,052576,66347,752-26,45766,773-1,03394,945
Deferred Taxes & Provisions
Cash flow from operations60,3611,833,7211,254,5651,992,346830,740241,155237,800261,959393,1361,077,050257,252190,833255,914892,71014,503
Investing Activities
capital expenditure-77,268-97,728-1,278,739-1,013,026-313,298-118,289-258,032-448,159-113,093
Change in Investments1,099,198-43,3493,03647,961-63,71610,156-28,93336,408-29,48032,9532,52542,02014,243-95,928676,772
cash flow from investments-1,099,19843,349-3,036-47,96163,716-10,156-48,335-134,136-1,249,259-1,045,979-315,823-160,309-272,275-352,231-789,865
Financing Activities
Bank loans-17,0007001,700-200-20090014,100
Group/Directors Accounts
Other Short Term Loans
Long term loans-215,514-373-16,697-14,621-14,502-16,106277,813
Hire Purchase and Lease Commitments-969-11,703-19,94732,619
other long term liabilities
share issue-28,93336,408-29,48032,9532,52542,02014,2434,0723,781,369
interest-7,766-8,411-9,487
cash flow from financing-232,514327-14,997-15,790-63,104-7,156285,56532,9532,52542,02014,2434,0723,781,369
cash and cash equivalents
cash-1,190,433-266,098648,2701,549,219739,68041,88573,81171,107-123,469209-21,29127,991-10,824236,224242,963
overdraft
change in cash-1,190,433-266,098648,2701,549,219739,68041,88573,81171,107-123,469209-21,29127,991-10,824236,224242,963

willowbrook hospice Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for willowbrook hospice. Get real-time insights into willowbrook hospice's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Willowbrook Hospice Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for willowbrook hospice by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other mid companies, companies in L34 area or any other competitors across 12 key performance metrics.

willowbrook hospice Ownership

WILLOWBROOK HOSPICE group structure

Willowbrook Hospice has 1 subsidiary company.

Ultimate parent company

WILLOWBROOK HOSPICE

02808633

1 subsidiary

WILLOWBROOK HOSPICE Shareholders

--

willowbrook hospice directors

Willowbrook Hospice currently has 15 directors. The longest serving directors include Dr Karen Beeby (Sep 2007) and Ms Elaine Inglesby (Oct 2009).

officercountryagestartendrole
Dr Karen Beeby70 years Sep 2007- Director
Ms Elaine Inglesby65 years Oct 2009- Director
Dr Michael Van Dessel67 years May 2014- Director
Ms Sarah Carberry59 years Sep 2019- Director
Mr Ian CraigScotland65 years Jul 2020- Director
Mr Ian Craig65 years Jul 2020- Director
Mr Stephen Fairhurst53 years Jul 2020- Director
Mr Jonathan Dobson68 years Jul 2020- Director
Dr Alan Baron67 years Nov 2022- Director
Mr Allan Sansbury66 years Nov 2023- Director

P&L

March 2024

turnover

5.9m

-4%

operating profit

-95k

0%

gross margin

34.8%

+3.96%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

March 2024

net assets

9.9m

0%

total assets

10.4m

0%

cash

2m

-0.37%

net assets

Total assets minus all liabilities

willowbrook hospice company details

company number

02808633

Type

Private Limited by guarantee without Share Capital Exempt from using Limited

industry

86101 - Hospital activities

incorporation date

April 1993

age

32

incorporated

UK

ultimate parent company

None

accounts

Group

last accounts submitted

March 2024

previous names

st helens and knowsley hospice (June 1999)

accountant

-

auditor

LIVESEY SPOTTISWOOD

address

portico lane, eccleston park, prescot, merseyside, L34 2QT

Bank

NATIONAL WESTMINSTER BANK PLC

Legal Advisor

-

willowbrook hospice Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to willowbrook hospice.

willowbrook hospice Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for WILLOWBROOK HOSPICE. This can take several minutes, an email will notify you when this has completed.

willowbrook hospice Companies House Filings - See Documents

datedescriptionview/download